UCSF Research Team Discovers New Methods of Determining Recurrence of Brain Tumors

After, patients with low-grade glioma, a type of brain cancer, undergo neurosurgery to remove the tumors, they face variable odds of survival that depend largely on how rapidly the cancer recurs. Even though their doctors monitor the tumors closely with sophisticated imaging, it’s hard to determine with certainty whether the cancer has returned in a more malignant state requiring aggressive treatment.

A team from the University of California, San Francisco (UCSF) has developed methods to reveal a molecular marker in tissue samples from brain tumors that has been tied to better survival odds. Monitoring this marker in the brain could give doctors a better way to follow their patients after surgery. For more information, click here to read the full release.